Abstract
We aimed to study the growth and growth factors of children with liver disease before and after liver transplantation (LT). Three observation intervals: 1) before LT (preLT), 2) after LT on daily prednisone treatment (dP), and 3) on alternate day prednisone (adP). A longitudinal study (LS) involved 17 infants (9 male) aged 0.73-2.38 y at LT; mean (±SD) height (Ht) SD score (SDS) at LT was -2.02 (± 1.25). In a cross-sectional study, there were 123 children (73 male) aged 0.16-14.88 y (mean 3.72 y). IGF-I and IGF binding proteins (BP) 1 and 3 were measured at the same intervals. The results were, for LS, preLT height velocity (HV) SDS(-X ± SD -0.8 ± 1.4) lower (p < 0.01) than adP-HV SDS (3.1 ± 1.8) but not different from dp-HV SDS(-1.0 ± 1.9). For the cross-sectional study, dP-Ht SDS(-X ± SD -1.94 ± 1.31) lower (p < 0.001) than preLT-Ht SDS (-1.03 ± 1.06) and adP-Ht SDS (-0.98 ± 1.20). Parental target SDS was not different from adP-Ht SDS. (Similar observations were made in the LS.) The dP- sitting height (SH) and subischial leg length (SLL) SDS were significantly lower than both preLT- and adP-SH SDS and SLL SDS (p = 0.02 and 0.002, respectively). There was a significant improvement of head circumference SDS and arm circumference SDS from preLT to adP. The dP and adP IGF-I and IGF-BP3 levels were greater than preLT levels (p < 0.001); no differences were found between preLT, dP, and adP IGF-BP1 levels. We conclude that growth in children with liver disease does not improve after LT on dP, but catch-up growth is shown on adP, appearing to depend mainly on the clinical course and corticosteroid regimen. IGF-I and IGF-BP3 increment on dP (and sustained on adP) is possibly due to liver regeneration, in contrast with inhibition of body growth on dP, possibly due to central and peripheral effects of corticosteroid.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- adP:
-
after LT on alternate-day prednisone treatment
- CS:
-
corticosteroids
- dP:
-
after LT on daily prednisone treatment
- HC:
-
head circumference
- Ht:
-
height
- HV:
-
height velocity
- BP:
-
binding protein
- LT:
-
liver transplantation
- preLT:
-
before liver transplantation
- SDS:
-
SD score
- SH:
-
sitting height
- SLL:
-
subischial leg length
- CV:
-
coefficient of variance
References
Starzl TE, Esquivel C, Gordon R, Todo S 1987 Pediatric liver transplantation. Transplant Proc 4: 3230–3235
Otte JB, deVille deGoyet J, de Hemptinne B, Kenstens PJ, Moulin D, Carlier MA, Claus D, Rahier J, Bots JP 1987 Liver transplantation in children: report of 2½ year's experience at the University of Leuvain Medical School in Brussels. Transplant Proc 4: 3289–3302
Salt A, Noble-Jameson G, Barnes ND, Mowat AP, Rolles K, Jamieson N, Johnson P, Friend P, Calue RY 1992 Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ 304: 416–421
Urbach AH, Gartner JC, Malateck JJ, Zitelli BJ, Iwatsuki S, Shaw BW, Starzl TE 1987 Linear growth following pediatric liver transplantation. Am J Dis Child 141: 547–549
Spolidoro JVN, Berquist VE, Pehlivanoghe E, Busuttil R, Saluski I, Vargas J, Ament ME 1988 Growth acceleration in children after orthotopic liver transplantation. J Pediatr 112: 41–44
Stewart SM, Uauy R, Waller DA, Kennarl BL, Bender M, Andrews WS 1989 Mental and motor development, social competence, and growth one year after successful pediatric liver transplantation. J Pediatr 114: 574–581
Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME 1990 Prediction of long-term linear growth following liver transplantation. Transplant Proc 22: 1558–1559
Sarna S, Sipilä I, Vihervuori E, Koistinen R, Holmberg C 1995 Growth delay after liver transplantation in childhood: studies of underlying mechanisms. Pediatr Res 38: 366–372
Jara P, Diaz MC, Hierro L, de la Vega A, Camarena C, Frauca E, Lama R, López Santamaria M, Vázquez J, Murcia J, Gámez M 1996 Growth and height in children after liver transplantation. Transplant Int 9( suppl 1): S160–S163
Preece MA 1976 The effect of administered corticosteroids on the growth of children. Postgrad Med J 52: 625–630
Avioli LV 1993 Glucocorticoid effects on statural growth. Br J Rheumatol 32( suppl 2): 27–30
Robinson ICAF, Gabrielsson B, Klaus G, Mauras N, Holmberg C, Mehls O 1995 Glucocorticoids and growth problems. Acta Paediatr Suppl 411: 81–86
Giustina A, Wehrenberg WB 1990 The role of glucocorticoids in the regulation of growth hormone secretion-mechanisms and clinical significance. Trends Endocrinol Metab 3: 306–311
Blizzard RM, Johanson A 1994 Disorders of growth. In: Kappy MS, Blizzard RM, Migeon CJ (eds) Wilkins Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Charles C Thomas Publisher, Springfield, IL, 384–388
Rogol AD, Root AW 1994 Regulation of the endocrine system. In: Kappy MS, Blizzard RM, Migeon CJ (eds) Wilkins Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Charles C Thomas Publisher, Springfield, IL, pp 77–78
Root AW, Rogol AD 1994 Organization and function of the endocrine system. In: Kappy MS, Blizzard RM, Migeon CJ (eds) Wilkins Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Charle C Thomas Publisher, Springfield, IL, pp 32–34
Cameron N 1986 Methods of auxological anthropometry. In: Falkner F, Tanner JM (eds) Human Growth, Vol III. Plenum Press, New York, pp 3–46
Tanner JM, Whitehouse RH, Takaishi M 1966 Standards from birth to maturity for height, weight, height velocity and weight velocity; British children 1965. Arch Dis Child 41: 454–471 and 613–635
Tanner JM 1978 Human growth standards: construction and use. In: Gedda L, Parisi P (eds) Auxology: Human Growth in Health and Disorder. Academic Press, London, 109–121
Hernandez M, Castellet J, Narvaiza JL, Rincon JM, Ruiz I, Sanchez E, Sobradillo B, Zurimendi A 1988 Curvas y tablas de crecimiento. Editorial Garsi, Madrid, pp 26–29
Morrell DJ, Dadi H, More J, Taylor AM, Dabestani A, Buchanan CR, Holder AT, Preece MA 1989 A monoclonal antibody to insulin-like growth factor I: characterization, use in radioimmunoassay and effect on biological activities of the growth factor. J Mol Endocrinol 2: 201–206
Povoa G, Roovete A, Hall K 1984 Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107: 563–570
Rees L, Green SA, Adlard P, Jones J, Haycock GB, Rigden SP, Preece MA, Chantler C 1988 Growth and endocrine function after renal transplantation. Arch Dis Child 63: 1326–1332
Shalet SM, Didi M, Ogilvy-Stuart AL, Shulga J, Donaldson MDC 1995 Growth and endocrine function after bone marrow transplantation. Clin Endocrinol 42: 333–339
Johansson G, Sietnieks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckw M, Holmberg C, Sipilä I, Broyer M, Rappaport R, Albertsson-Wikland K, Berg U, Jodal U, Rees L, Rigden SPA, Preece MA 1990 Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report of five European studies. Acta Paediatr Scand Suppl 370: 36–42
Shalet SM 1991 Growth hormone therapy following bone marrow transplantation in childhood. Bone Marrow Transplant 8( suppl 1): 14.
Mehls O, Broyer M (on behalf of the European/Australian Study Group) 1994 Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. Acta Paediatr Suppl 339 : 81–87
Mehls O, Tönshoff B, Blum WF, Heinrich U, Seidel C 1990 Growth hormone and insulin-like growth factor I in chronic renal failure-pathophysiology and rationale for growth hormone treatment. Acta Paediatr Scand Suppl 370: 28–34
Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stöver B, Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts 1993 Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int 44: 199–207
Sarna S, Sipilä I, Holmberg C 1996 Recombinant human growth hormone treatment after liver transplantation in children. Horm Res 46( suppl 2): 44.
Giustina A, Girelli A, Alberti D, Bossoni S, Buzi F, Doga M, Schettino M, Wehrenberg WB 1991 Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin Endocrinol 35: 491–498
Busby WH, Snyder DK, Clemmons DR 1988 Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab 67: 1225–1230
Author information
Authors and Affiliations
Additional information
Supported by Pharmacia-Upjohn-Italia.
Rights and permissions
About this article
Cite this article
Buzi, F., Bontempelli, A., Alberti, D. et al. Growth, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Proteins 1 and 3 in Children with Severe Liver Disease before and after Liver Transplantation: A Longitudinal and Cross-Sectional Study. Pediatr Res 43, 478–483 (1998). https://doi.org/10.1203/00006450-199804000-00007
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199804000-00007
